HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D M Goldenberg Selected Research

arcitumomab

11/2000Can postoperative surveillance with serial CEA immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free survival?
6/2000Safety and efficacy of arcitumomab imaging in colorectal cancer after repeated administration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D M Goldenberg Research Topics

Disease

32Neoplasms (Cancer)
01/2021 - 01/2000
6B-Cell Lymphoma (Lymphoma, B Cell)
06/2005 - 07/2000
5Lymphoma (Lymphomas)
05/2007 - 01/2001
5Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2006 - 06/2000
4Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 06/2000
4Breast Neoplasms (Breast Cancer)
12/2020 - 07/2000
3Colonic Neoplasms (Colon Cancer)
12/2000 - 04/2000
2Neoplasm Metastasis (Metastasis)
01/2021 - 06/2000
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2013 - 04/2008
2medullary Thyroid cancer
09/2009 - 01/2000
2Eosinophilia
11/2001 - 06/2000
2Endometriosis
11/2001 - 05/2000
2Carcinoma (Carcinomatosis)
06/2001 - 11/2000
1Triple Negative Breast Neoplasms
01/2021
1Disease Progression
01/2021
1Virus Diseases (Viral Diseases)
12/2017
1Autoimmune Diseases (Autoimmune Disease)
04/2008
1Hematologic Neoplasms (Hematological Malignancy)
05/2007
1Thyroid Neoplasms (Thyroid Cancer)
02/2005
1Ovarian Neoplasms (Ovarian Cancer)
11/2003
1Multiple Myeloma
02/2003
1Hypoxia (Hypoxemia)
11/2001
1Small Cell Carcinoma
07/2001
1Pancreatic Neoplasms (Pancreatic Cancer)
07/2001
1Lung Neoplasms (Lung Cancer)
06/2001
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2001
1Rectal Neoplasms (Rectal Cancer)
11/2000

Drug/Important Bio-Agent (IBA)

14Monoclonal AntibodiesIBA
01/2021 - 01/2000
9Carcinoembryonic AntigenIBA
01/2021 - 01/2000
6Peptides (Polypeptides)IBA
01/2021 - 11/2000
6Radioisotopes (Radionuclides)IBA
08/2013 - 07/2000
6Immunoglobulin G (IgG)IBA
06/2005 - 12/2000
5AntigensIBA
05/2007 - 01/2001
3sacituzumab govitecanIBA
01/2021 - 12/2020
3Immunoconjugates (Immunoconjugate)IBA
01/2021 - 05/2007
3epratuzumabIBA
04/2013 - 05/2007
3Pharmaceutical PreparationsIBA
04/2008 - 10/2001
3AntibodiesIBA
05/2007 - 12/2000
3Fluorouracil (Carac)FDA LinkGeneric
01/2003 - 02/2000
2DOTA- tyrosyl- lysyl(histaminyl- succinyl- glycyl)- glutamyl- lysyl(histaminyl- succinyl- glycyl)amideIBA
01/2021 - 08/2013
2Surface Antigens (Surface Antigen)IBA
01/2021 - 05/2007
2Immunoglobulin FragmentsIBA
02/2014 - 12/2000
2HaptensIBA
08/2013 - 11/2000
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2010 - 01/2000
2Proteins (Proteins, Gene)FDA Link
11/2003 - 07/2000
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2003 - 02/2000
2CytokinesIBA
02/2003 - 01/2000
2Mucin-1 (CA 15-3 Antigen)IBA
02/2003 - 01/2003
2Eosinophil PeroxidaseIBA
11/2001 - 05/2000
2Ribonucleases (Ribonuclease)IBA
07/2001 - 01/2001
2invariant chain (Ii-Key)IBA
06/2001 - 07/2000
2arcitumomabFDA Link
11/2000 - 06/2000
1Biomarkers (Surrogate Marker)IBA
01/2021
1GemcitabineFDA Link
01/2021
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2021
1Irinotecan (Camptosar)FDA LinkGeneric
01/2021
1Capecitabine (Xeloda)FDA Link
01/2021
1eribulinFDA Link
01/2021
1Topoisomerase InhibitorsIBA
01/2021
1Hormones (Hormone)IBA
12/2020
1EpitopesIBA
12/2017
1Keratin-19 (Keratin 19)IBA
06/2010
1Phosphotransferases (Kinase)IBA
06/2010
1VimentinIBA
06/2010
1Immunoglobulins (Immunoglobulin)IBA
04/2008
1Carboplatin (JM8)FDA LinkGeneric
11/2003
1Paclitaxel (Taxol)FDA LinkGeneric
11/2003
1Topotecan (Hycamtin)FDA LinkGeneric
11/2003
1Messenger RNA (mRNA)IBA
02/2003
1Interferon-gamma (Interferon, gamma)IBA
02/2003
1colon-specific antigenIBA
01/2003
1Bispecific AntibodiesIBA
09/2002
1Oxygen (Dioxygen)IBA
11/2001
1Cytotoxins (Cytolysins)IBA
11/2001
1Tirapazamine (SR 4233)IBA
11/2001
1dimemorfan (AT 17)IBA
10/2001
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
10/2001
1Celecoxib (Celebrex)FDA Link
10/2001
1RNA (Ribonucleic Acid)IBA
07/2001
1tositumomab I-131 (Bexxar)FDA Link
07/2001
1ibritumomab tiuxetan (Zevalin)FDA Link
07/2001
1GalliumIBA
06/2001
1IndiumIBA
06/2001
1YttriumIBA
06/2001
1Therapeutic UsesIBA
06/2001
1ranpirnase (Pannon)IBA
01/2001
1Pancreatic Ribonuclease (Ribonuclease A)IBA
01/2001
1Leucovorin (Folinic Acid)FDA Link
12/2000
1Pentetic Acid (DTPA)FDA LinkGeneric
11/2000
1Inosine Monophosphate (IMP)IBA
11/2000
1technetium Tc-99m arcitumomabFDA Link
11/2000
1Complement System Proteins (Complement)IBA
07/2000

Therapy/Procedure

19Therapeutics
04/2008 - 01/2000
14Radioimmunotherapy
09/2009 - 01/2000
7Drug Therapy (Chemotherapy)
01/2021 - 02/2000
1Electrodes (Electrode)
11/2001
1Microelectrodes
11/2001
1Chronotherapy
10/2001
1Salvage Therapy
11/2000
1Second-Look Surgery
11/2000